-
#BreakingNews:#RespireRx#Pharmaceuticals Inc. Announces the Filing of Broad Enabling#Cannabinoid Continuation-in-Part & New Provisional#Patent Applications http://www.globenewswire.com/news-release/2020/02/03/1978760/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Appointment-of-Tim-Jones-to-its-Board-of-Directors.html …#cannabisinvestors#cbd#StockMarket$RSPI#CannabisCommunity#cannastock#cannabizpic.twitter.com/zUjR8wg3lt
-
#RespireRx Announces Board of Directors Appointment | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology https://www.americanpharmaceuticalreview.com/1315-News/560377-RespireRx-Announces-Board-of-Directors-Appointment/ … via@AmPharmRev$RSPI -
#NEWS:#RespireRx#Pharmaceuticals Inc. Announces Appointment of Tim Jones to its Board of Directors - https://mailchi.mp/0a19c998ff86/press-releaserespirerx-pharmaceuticals-1-3-1260503 …#cannabinoid#dronabinol#pennystocks#StockMarket#stockstowatch$RSPI#sleeapnea#biotech#biotechstock#ampakine#CannabisCommunity#cannastockpic.twitter.com/PQAnxVKoQS
-
Joe Rogan Explains Why Athletes Should Be Worried About Sleep Apnea https://www.dexerto.com/entertainment/joe-rogan-explains-why-athletes-should-be-worried-about-sleep-apnea-1317020 … Via
@joerogan "According to the CDC, 1 in 3 Americans don't get enough rest, and one of the leading causes is#SleepApnea"#joerogan#sleep#Breathing$RSPI#respirerx#pennystock#stocks -
#RespireRx is developing a pipeline of new drug products based on our broad patent portfolios for 2 drug platforms:#cannabinoids, including#dronabinol (D9-#THC), and the ampakines...http://respirerx.com/wp-content/uploads/2017/07/Ampakines-Platform-Summary-Final.pdf …#SleepApnea#potstocks$RSPI#CannabisCommunity#cannabisindustrypic.twitter.com/blgMgAUn0b
-
Interview with the Executive Chairman:
#RespireRx#Pharmaceuticals Inc. (OTCMKTS:$RSPI) https://www.twst.com/interview/interview-with-the-executive-chairman-respirerx-pharmaceuticals-inc-otcmktsrspi …#pennystock#stock#WallStreet#biopharma#sleepapnea#CannabisNews -
The Daily Marijuana Observer:
#Biotech Marijuana Stocks -#RespireRX#Pharmaceuticals Inc. (OTC:RSPI) https://www.dailymarijuanaobserver.com/respirerx-rspi@dailymjobserver$RSPI#stocks#CannabisCommunity -
Panel Discussion: The
#Investor’s Perspective on the#Cannabinoid#Pharmaceuticals Field.”#RespireRx Pharmaceuticals Inc. Executives Participating in the 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit http://respirerx.com/wp-content/uploads/2019/09/2nd-Annual-Intl-Cannabinoid-Derived-Pharmaceuticals-Summit-RSPI.pdf …#CannabisCommunity$RSPI#stockspic.twitter.com/nZnOvtEpMn
-
#RespireRx#Pharmaceuticals Inc. Executives Participating in the 2nd Annual International#Cannabinoid Derived Pharmaceuticals Summit “RespireRx is at the forefront of developing#cannabinoids for the treatment of neurologically based diseases because w…https://lnkd.in/gDF7fyZ -
Impression Healthcare teams up with Cannvalate in ‘first of its kind’
#medicalcannabis trial and distribution deal.$IHL$RSPI#pennystocks#drugdevelopment#cannabiscommunity#clinicaltrials#RespireRx#sleepapnea#clinicaltrialhttps://lnkd.in/gUiSSea -
(Omaha)
#RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol for the Treatment of Obstructive Sleep Apnea (#OSA) in Australia, New Zealand and Southeast Asia : Glen Rock, .. https://www.storiesflow.com/14025151901/osa-respirerx-pharmaceuticals-impression-healthcare-limited-agreement-explore-commercialization-dronabinol-treatment-obstructive-sleep-apnea-australia-zealand-southeast-asia … -
#Global Obstructive Sleep Apnoea#Devices market = US$5.5B in 2017$IHL executed a memorandum of understanding +#Exclusivity Agreement with#RespireRx Pharmaceuticals to negotiate the terms for$IHL to#License#Partner#Complete a#joint-venture with#Respire for#dronabinolhttps://twitter.com/gassin123Charts/status/1096170840192835584 … -
Press Release:
#RespireRx#Pharmaceuticals Inc. Executives Presenting at the International#Cannabinoid Derived Pharmaceuticals Summit#sleepapnea#iCDP$RSPI#biopharmaceuticals#cannabis#news#pharmacology#pennystock#health#drugdevelopmenthttps://lnkd.in/eiqxvYf
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.